Sep 24, 2026 06:11AM
Sep 21, 2026 04:05PM
Aug 5, 2026 11:14AM
Aug 5, 2026 09:55AM
Aug 5, 2026 12:47AM
Jun 25, 2026 07:40AM
Jun 16, 2026 04:30PM Travere Therapeutics names new R&D head ahead of 2027 retirement
Jun 15, 2026 05:35AM
Jun 3, 2026 12:53PM
Jun 2, 2026 11:38AM
Jun 2, 2026 07:01AM
May 4, 2026 04:02PM
Apr 24, 2026 08:00AM
Apr 24, 2026 06:45AM Travere Therapeutics (TVTX) PT Raised to $56 at Guggenheim
Apr 14, 2026 03:07PM
Apr 14, 2026 11:10AM
Apr 14, 2026 10:45AM
Apr 14, 2026 09:13AM
Apr 14, 2026 08:52AM
Apr 14, 2026 07:08AM
Apr 14, 2026 07:07AM Travere Therapeutics (TVTX) Reiterated at Overweight by Cantor Fitzgerald on FSGS Approval
Apr 14, 2026 06:47AM
Mar 24, 2026 05:03AM
Feb 19, 2026 04:01PM
Jan 16, 2026 01:20PM
Jan 14, 2026 06:48AM
Jan 13, 2026 01:24PM
Jan 13, 2026 12:42PM Travere Therapeutics (TVTX) Halted, News Pending
Jan 13, 2026 07:27AM
Jan 13, 2026 04:57AM
Jan 12, 2026 05:00PM
Dec 24, 2025 11:54AM
Dec 23, 2025 05:30PM
Oct 31, 2025 09:04AM
Oct 30, 2025 04:07PM Travere Therapeutics (TVTX) Tops Q3 EPS by 88c
Sep 26, 2025 07:02AM
Sep 22, 2025 06:45AM
Sep 11, 2025 06:48AM
Sep 10, 2025 11:01AM
Sep 10, 2025 10:30AM
Sep 10, 2025 10:11AM
Sep 10, 2025 09:58AM Cantor Fitzgerald Comments on Travere Therapeutics (TVTX) Amid Shares Gaining 22pct
Sep 10, 2025 07:01AM
Sep 4, 2025 06:42AM
Aug 28, 2025 07:33AM
Aug 7, 2025 10:06AM
Aug 6, 2025 04:03PM
Jun 11, 2025 06:19AM
Jun 11, 2025 04:58AM Travere Therapeutics (TVTX) PT Lowered to $32 at Citi, Adds 90d Upside Catalyst Watch
May 19, 2025 03:38PM

459,885 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All